Combined supplementation of vanadium and 1α,25-dihydroxyvitamin D3 inhibit diethylnitrosamine-induced rat liver carcinogenesis
- 15 August 2000
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 128 (1) , 1-18
- https://doi.org/10.1016/s0009-2797(00)00183-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivityJournal of Cellular Biochemistry, 1997
- Synergistic Induction of HL60 Cell Differentiation by Ketoconazole and 1-Desoxy Analogues of Vitamin D3JNCI Journal of the National Cancer Institute, 1997
- 1,25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Act Synergistically to Inhibit the Growth of LNCaP Prostate Cells and Cause Accumulation of Cells in G1*Endocrinology, 1997
- Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbitalBritish Journal of Cancer, 1995
- Alterations in enzymes in an Indian catfish, Clarias batrachus (Linn.), exposed to vanadiumBulletin of Environmental Contamination and Toxicology, 1995
- Increased lipid peroxidation in tissues of the catfish Clarias batrachus following vanadium treatment: In vivo and in vitro evaluationJournal of Inorganic Biochemistry, 1994
- Oncogenes, ions, and phospholipidsAmerican Journal of Physiology-Cell Physiology, 1985
- Vanadium stimulates the (Na+,K+) pump in friend erythroleukemia cells and blocks erythropoiesis.The Journal of cell biology, 1983
- Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamineNature, 1978
- The effect of antilymphocytic and normal horse serum on growth of precancerous foci and development of tumours induced by diethylnitrosamine in rat liverPublished by Elsevier ,1976